285 results on '"Samai, Mohamed"'
Search Results
2. Prevalence and risk factors associated with malaria infection in children under two years of age in southern Togo prior to perennial malaria chemoprevention implementation
3. Coverage of intermittent preventive treatment of malaria in infants after four years of implementation in Sierra Leone
4. Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in infants: a phase 2, randomised, double-blind, active-controlled trial in Guinea and Sierra Leone
5. A new simplified approach for predicting the bearing capacity of rectangular concrete four-pile caps
6. Prevalence of immunoglobulin G and M to SARS-CoV-2 and other human coronaviruses in The Democratic Republic of Congo, Sierra Leone, and Uganda: A longitudinal study
7. Immune response of a two-dose heterologous Ebola vaccine regimen: summary of three African clinical trials using a single validated Filovirus Animal Nonclinical Group enzyme-linked immunosorbent assay in a single accredited laboratory
8. Safety and immunogenicity of an Ad26.ZEBOV booster dose in children previously vaccinated with the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen: an open-label, non-randomised, phase 2 trial
9. Incidence and risk factors of surgical site infections and related antibiotic resistance in Freetown, Sierra Leone: a prospective cohort study
10. Factors influencing adherence to antiretroviral therapy from the experience of people living with HIV and their healthcare providers in Sierra Leone: a qualitative study
11. Impact of oral azithromycin and intermittent preventive treatment with sulfadoxine-pyrimethamine regimen on child mortality in Sierra Leone: trial protocol for a randomised, two-arm, double-blinded, placebo-controlled clinical trial (ICARIA).
12. Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trial
13. Safety and long-term immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: a combined open-label, non-randomised stage 1, and a randomised, double-blind, controlled stage 2 trial
14. An Assessment of Medication Errors Among Pediatric Patients in Three Hospitals in Freetown Sierra Leone: Findings and Implications for a Low-Income Country
15. Second-order analysis of plane steel structures using Rankine-Merchant-Wood approach
16. Immunisation coverage and factors associated with incomplete immunisation in children under two during the COVID-19 pandemic in Sierra Leone
17. An Assessment of Medication Errors Among Pediatric Patients in Three Hospitals in Freetown Sierra Leone: Findings and Implications for a Low-Income Country
18. Immunisation coverage and factors associated with incomplete immunisation in children under two during the COVID-19 pandemic in Sierra Leone
19. PA-605 Acceptability and feasibility of perennial malaria chemoprevention for children under two years: a mixed method pre-implementation assessment in Togo (MULTIPLY project)
20. PA-566 Acceptability and feasibility of a pilot malaria prevention strategy for children under two years in Sierra Leone: a mixed methods study among health care workers
21. PA-466 Factors associated with coverage of three doses of intermittent preventive treatment of malaria in infants with Sulfadoxine-pyrimethamine: a cross-sectional community-based survey in Sierra Leone
22. PA-574 Prevalence and factors associated with malaria infection in children aged 10 to 23 months in Togo in 2022
23. Pregnancy Outcomes among Women Receiving rVSV[DELTA]-ZEBOV-GP Ebola Vaccine during the Sierra Leone Trial to Introduce a Vaccine against Ebola
24. Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in infants: a phase 2, randomised, double-blind, active-controlled trial in Guinea and Sierra Leone
25. The Sierra Leone Trial to Introduce a Vaccine Against Ebola : An Evaluation of rVSVΔG-ZEBOV-GP Vaccine Tolerability and Safety During the West Africa Ebola Outbreak
26. Participant Retention in a Randomized Clinical Trial in an Outbreak Setting : Lessons From the Sierra Leone Trial to Introduce a Vaccine Against Ebola (STRIVE)
27. Monitoring Serious Adverse Events in the Sierra Leone Trial to Introduce a Vaccine Against Ebola
28. Health Conditions in an Adult Population in Sierra Leone : Data Reported From the Sierra Leone Trial to Introduce a Vaccine Against Ebola (STRIVE)
29. Operationalizing International Regulatory Standards in a Limited-Resource Setting During an Epidemic : The Sierra Leone Trial to Introduce a Vaccine Against Ebola (STRIVE) Experience
30. Implementing a Multisite Clinical Trial in the Midst of an Ebola Outbreak : Lessons Learned From the Sierra Leone Trial to Introduce a Vaccine Against Ebola
31. Clinical Surveillance and Evaluation of Suspected Ebola Cases in a Vaccine Trial During an Ebola Epidemic : The Sierra Leone Trial to Introduce a Vaccine Against Ebola
32. Rapid Establishment of a Cold Chain Capacity of –60°C or Colder for the STRIVE Ebola Vaccine Trial During the Ebola Outbreak in Sierra Leone
33. Lessons Learned in Clinical Trial Communication During an Ebola Outbreak : The Implementation of STRIVE
34. Novel superoxide dismutase mimetics for protection against paraquat nephrotoxicity
35. The Effect of Previous Exposure to Malaria Infection and Clinical Malaria Episodes on the Immune Response to the Two-Dose Ad26.ZEBOV, MVA-BN-Filo Ebola Vaccine Regimen
36. African Medicines Agency: How it will change the landscape of medicines in Africa
37. A cross-sectional study on caregivers’ perspective of the quality of life and adherence of paediatric HIV patients to highly active antiretroviral therapy
38. The Theoretical Prediction of Collapse Mechanisms for Masonry-Infilled Steel Frames
39. Prediction of Collapse Mechanisms by the Construction Interaction Diagrams for Plane Steel Structures
40. Top 10 public health challenges to track in 2023: Shifting focus beyond a global pandemic
41. Prevalence of IgG and IgM to SARS-CoV-2 and other human coronaviruses in The Democratic Republic of Congo, Sierra Leone and Uganda: A Longitudinal Study
42. Additional file 2 of Coverage of intermittent preventive treatment of malaria in infants after four years of implementation in Sierra Leone
43. Additional file 1 of Coverage of intermittent preventive treatment of malaria in infants after four years of implementation in Sierra Leone
44. Randomized Trial of Vaccines for Zaire Ebola Virus Disease
45. Burns in Sierra Leone: A population-based assessment
46. The monkeypox virus: A public health challenge threatening Africa
47. Strengthening ethics committees for health-related research in sub-Saharan Africa: a scoping review
48. The bumpy trajectory of performance-based financing for healthcare in Sierra Leone: agency, structure and frames shaping the policy process
49. Prevalence of malaria and helminth infections in rural communities in northern Sierra Leone, a baseline study to inform Ebola vaccine study protocols
50. Hepatitis B Virus and Tuberculosis Are Associated with Increased Noncommunicable Disease Risk among Treatment-Naïve People with HIV: Opportunities for Prevention, Early Detection and Management of Comorbidities in Sierra Leone
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.